Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
University of Chicago
Gustave Roussy, Cancer Campus, Grand Paris
Pfizer
Hoffmann-La Roche
Insel Gruppe AG, University Hospital Bern
Luzerner Kantonsspital
EMD Serono
University of Wisconsin, Madison
University of Arizona
Boehringer Ingelheim
Institut de cancérologie Strasbourg Europe
Takeda
Gustave Roussy, Cancer Campus, Grand Paris
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Tempus AI
Actym Therapeutics, Inc.
EMD Serono
University of Pennsylvania
Bolt Biotherapeutics, Inc.
Ascendis Pharma A/S
Icahn School of Medicine at Mount Sinai
University of California, San Diego
AHS Cancer Control Alberta
University of Exeter
Regeneron Pharmaceuticals
Thomas Jefferson University
M.D. Anderson Cancer Center
Elevation Oncology
M.D. Anderson Cancer Center
Henry Ford Health System
Alentis Therapeutics AG
Wake Forest University Health Sciences
OHSU Knight Cancer Institute
University Hospital Schleswig-Holstein
Aminex Therapeutics, Inc.
University of Wisconsin, Madison
University of Wisconsin, Milwaukee
Washington University School of Medicine
Mayo Clinic
Atara Biotherapeutics
Case Comprehensive Cancer Center
Rakuten Medical, Inc.
Inhibrx Biosciences, Inc
Novartis
GlaxoSmithKline
Merck Sharp & Dohme LLC
Medical College of Wisconsin
The Netherlands Cancer Institute